Add-On Effect of Hemagglutinating Virus of Japan Envelope Combined with Chemotherapy or Immune Checkpoint Inhibitor against Malignant Pleural Mesothelioma: An In Vivo Study

SIMPLE SUMMARY: In this study, we report that the combination of existing therapeutic agents and hemagglutinating virus of Japan envelope (HVJ-E), a virus-inactivating agent, may be a more effective treatment agent for pleural mesothelioma, a refractory cancer for which no effective treatment has be...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakura, Kazuma, Sasai, Masao, Funaki, Soichiro, Shintani, Yasushi, Okumura, Meinoshin, Kaneda, Yasufumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913709/
https://www.ncbi.nlm.nih.gov/pubmed/36765886
http://dx.doi.org/10.3390/cancers15030929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913709/
https://www.ncbi.nlm.nih.gov/pubmed/36765886
http://dx.doi.org/10.3390/cancers15030929

Ejemplares similares